Geode Capital Management’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.41M | Sell |
918,533
-44,736
| -5% | -$166K | ﹤0.01% | 2926 |
|
|
2025
Q1 | $3.11M | Sell |
963,269
-48,893
| -5% | -$158K | ﹤0.01% | 2869 |
|
|
2024
Q4 | $5.64M | Sell |
1,012,162
-24,383
| -2% | -$136K | ﹤0.01% | 2682 |
|
|
2024
Q3 | $11.2M | Sell |
1,036,545
-24,346
| -2% | -$263K | ﹤0.01% | 2312 |
|
|
2024
Q2 | $22.3M | Buy |
1,060,891
+188,228
| +22% | +$3.95M | ﹤0.01% | 1875 |
|
|
2024
Q1 | $27.8M | Buy |
872,663
+94,501
| +12% | +$3.01M | ﹤0.01% | 1727 |
|
|
2023
Q4 | $15.8M | Buy |
778,162
+36,497
| +5% | +$739K | ﹤0.01% | 2054 |
|
|
2023
Q3 | $9.44M | Buy |
741,665
+51,888
| +8% | +$661K | ﹤0.01% | 2303 |
|
|
2023
Q2 | $12.5M | Buy |
689,777
+111,855
| +19% | +$2.02M | ﹤0.01% | 2152 |
|
|
2023
Q1 | $9.93M | Buy |
577,922
+16,185
| +3% | +$278K | ﹤0.01% | 2259 |
|
|
2022
Q4 | $12.5M | Buy |
561,737
+32,801
| +6% | +$729K | ﹤0.01% | 2103 |
|
|
2022
Q3 | $4.25M | Buy |
528,936
+36,111
| +7% | +$290K | ﹤0.01% | 2757 |
|
|
2022
Q2 | $3.44M | Buy |
492,825
+14,202
| +3% | +$99.1K | ﹤0.01% | 2900 |
|
|
2022
Q1 | $7.24M | Sell |
478,623
-3,814
| -0.8% | -$57.7K | ﹤0.01% | 2575 |
|
|
2021
Q4 | $10.6M | Buy |
482,437
+140,219
| +41% | +$3.08M | ﹤0.01% | 2406 |
|
|
2021
Q3 | $9.23M | Buy |
342,218
+174,784
| +104% | +$4.71M | ﹤0.01% | 2505 |
|
|
2021
Q2 | $4.03M | Buy |
167,434
+21,136
| +14% | +$509K | ﹤0.01% | 3030 |
|
|
2021
Q1 | $6.35M | Buy |
146,298
+133,518
| +1,045% | +$5.79M | ﹤0.01% | 2663 |
|
|
2020
Q4 | $529K | Buy |
+12,780
| New | +$529K | ﹤0.01% | 3573 |
|